NewLink Genetics (NLNK) Tops Q3 EPS by 20c

NewLink Genetics (NASDAQ: NLNK) reported Q3 EPS of ($0.20), $0.20 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $2.8 million versus the consensus estimate of $310 thousand.

For earnings history and earnings-related data on NewLink Genetics (NLNK) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Cisco rating cut at HSBC as analyst sees a lack of catalysts
• Reading (RDI) Tops Q2 EPS by 4c